RYNEX DM Trademark

Trademark Overview

On Monday, May 5, 2014, a trademark application was filed for RYNEX DM with the United States Patent and Trademark Office. The USPTO has given the RYNEX DM trademark a serial number of 86271214. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 26, 2025. This trademark is owned by Edwards Pharmaceuticals, Inc.. The RYNEX DM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for use as a decongestant and antihistamine in the form of liquid for treating allergic rhinitis, respiratory allergies and cough
rynex dm

General Information

Serial Number86271214
Word MarkRYNEX DM
Filing DateMonday, May 5, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 26, 2025
Registration Number4698647
Registration DateTuesday, March 10, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparation for use as a decongestant and antihistamine in the form of liquid for treating allergic rhinitis, respiratory allergies and cough
NOT AVAILABLE"DM"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 26, 2025
Primary Code005
First Use Anywhere DateTuesday, February 22, 2011
First Use In Commerce DateTuesday, February 22, 2011

Trademark Owner History

Party NameEdwards Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBerwyn, PA 19312
Party NameEdwards Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRipley, MS 38663
Party NameEdwards Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRipley, MS 38663

Trademark Events

Event DateEvent Description
Saturday, August 23, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 8, 2014NEW APPLICATION ENTERED
Friday, May 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 19, 2014ASSIGNED TO EXAMINER
Saturday, August 23, 2014NON-FINAL ACTION WRITTEN
Saturday, August 23, 2014NON-FINAL ACTION E-MAILED
Monday, October 27, 2014ASSIGNED TO LIE
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, August 31, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 30, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 18, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 31, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 17, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 17, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 10, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sunday, February 21, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, February 21, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sunday, March 10, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 26, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, February 21, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, December 23, 2020TEAS SECTION 8 RECEIVED

Related Keywords

rynex rhinitis allergic respiratory allergies cough treating liquid preparation decongestant antihistamine